Aberrant TGFβ signalling contributes to dysregulation of sphingolipid metabolism in intrauterine growth restriction

TODROS, Tullia;
2015-01-01

100
7
986
996
http://press.endocrine.org/doi/pdf/10.1210/jc.2015-1288
Case-Control Studies; Cells, Cultured; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Lipid Metabolism; Lipid Metabolism Disorders; Placenta; Pregnancy; Signal Transduction; Sphingolipids; Term Birth; Transforming Growth Factor beta; Biochemistry; Clinical Biochemistry; Endocrinology; Biochemistry (medical); Endocrinology, Diabetes and Metabolism; Medicine (all)
Chauvin, Sarah; Yinon, Yoav; Xu, Jing; Ermini, Leonardo; Sallais, Julien; Tagliaferro, Andrea; Todros, Tullia; Post, Martin; Caniggia, Isabella
File in questo prodotto:
File Dimensione Formato  
jc%2E2015-1288.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 1.76 MB
Formato Adobe PDF
1.76 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1564599
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 25
social impact